View Author
virus fluenza noroviru outbreak resident infection disease fluenza virus oseltamivir susceptibility resistance fluenza viruses patient netherland mortality norovirus disease adamantane hc building institution study analysis risk factors symptom lourde signi statin building cohort table outbreak period gastroenteriti death factor 2005–2006 score strain 2007–2008 result adamantane-resistant ic 50 values period substitution zanamivir pilgrimage group outlier 2006–2007 journal addition epidemic neuraminidase variant season speci sequence nai susceptibility amantadine value norovirus outbreak adamantane resistance adamantane-sensitive clade acid substitution surveillance retrospective cohort study fluenza b virus epidemiology research fluenza season ficant investigation sample october health 1.000 acid substitutions 30 september smoking norovirus case mutation
4 Most Recent Publications
|
Unrecognized norovirus infections in health care institutions and their clinical impact
(Article)
Beersma, M.F.C. Sukhrie, F.H.A. Bogerman, J. Verhoef, L. Melo, M.M. de Vonk, A.G. Koopmans, M.P.G. |
2012-09-01
|
|
Quantifying transmission of norovirus during an outbreak
(Article)
Heijne, J.C.M. Rondy, M. Verhoef, L. Wallinga, J. Kretzschmar, M. Low, N. Koopmans, M.P.G. Teunis, P. |
2012-03-01
|
|
Norovirus disease associated with excess mortality and use of statins: A retrospective cohort study of an outbreak following a pilgrimage to Lourdes
(Article)
Rondy, M. Koopmans, M.P.G. Pelt, W. van Verhoef, L. Rotsaert, C. Loon, T. van Beljaars, B. Dijk, G. van Siebenga, J.J. Svraka-Latifovic, S. Rossen, J.W. Teunis, P. |
2011-03-01
|
|
Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008
(Article)
Jonges, M. Lubben, I.M. van der Dijkstra, F. Verhoef, L. Koopmans, M.P.G. Meijer, A. |
2009-09-01
|